tiprankstipranks
Supernus Pharmaceuticals (SUPN)
:SUPN
US Market

Supernus Pharmaceuticals (SUPN) Income Statement

Compare
501 Followers

Supernus Pharmaceuticals Income Statement

Last quarter (Q4 2024), Supernus Pharmaceuticals's total revenue was $174.16M, an increase of 5.99% from the same quarter last year. In Q4, Supernus Pharmaceuticals's net income was $15.33M. See Supernus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 661.82M$ 607.52M$ 667.24M$ 579.77M$ 520.40M
Gross Profit
$ 583.91M$ 523.74M$ 580.02M$ 504.71M$ 467.94M
Operating Expenses
$ 502.25M$ 529.01M$ 534.40M$ 425.21M$ 292.34M
Depreciation and Amortization
$ 80.41M$ 84.86M$ 85.63M$ 32.59M$ 20.00M
EBITDA
$ 178.28M$ 90.04M$ 153.44M$ 129.19M$ 212.40M
Operating Income
$ 81.67M$ -5.27M$ 67.30M$ 86.03M$ 173.70M
Other Income/Expenses
$ 16.20M$ 8.04M$ 14.62M$ -12.85M$ -5.05M
Pretax Income
$ 97.87M$ 2.77M$ 60.74M$ 73.17M$ 168.65M
Net Income
$ 73.86M$ 1.32M$ 60.71M$ 53.42M$ 126.95M
Per Share Metrics
Basic EPS
$ 1.34$ 0.02$ 1.13$ 1.01$ 2.41
Diluted EPS
$ 1.32$ 0.02$ 1.04$ 0.98$ 2.36
Weighted Average Shares Outstanding
55.10M 54.54M 53.67M 53.10M 52.62M
Weighted Average Shares Outstanding (Diluted)
55.96M 55.51M 61.68M 54.36M 53.69M
Currency in USD

Supernus Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis